Literature DB >> 7457402

Treatment of Prinzmetal's variant angina. Role of medical treatment with nifedipine and surgical coronary revascularization combined with plexectomy.

M E Bertrand, J M Lablanche, P Y Tilmant.   

Abstract

This study describes three forms of treatment of Prinzmetal's variant angina. Coronary spasm, frequently found at coronary arteriography in patients with Prinzmetal's variant angina, can be treated with intravenous or intracoronary injection of nitroglycerin as well as of nifedipine. Nifedipine (0.2 mg) was injected directly into the involved artery in 12 patients and suppressed spasm in 9; in 3 patients, nifedipine increased coronary sinus flow, which had been decreased by spasm in one of the branches of the left coronary artery. Patients with Prinzmetal's variant angina who have spasm superimposed on atherosclerotic lesions can benefit from coronary arterial bypass grafting combined with partial denervation of the heart. This combination yielded acceptable results (83.4 percent favorable outcome); recurrence of attacks occurred in only 6.7 percent of this group. In those forms of angina in which spasm occurs in angiographically normal coronary arteries, therapy is essentially medical. In 13 patients treated with oral nifedipine (30 to 40 mg/day), suppression of attacks was achieved in 11 instances. During the period of treatment, the methergine provocative test, which had been consistently positive before treatment, converted to negative in 12 patients. Transient withdrawal of nifedipine caused recurrence of pain in two patients.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7457402     DOI: 10.1016/0002-9149(81)90306-4

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  10 in total

1.  Action of nifedipine in ischemic heart disease.

Authors:  D D Miller; P Théroux; D D Waters; G B Pelletier
Journal:  Can Fam Physician       Date:  1983-04       Impact factor: 3.275

Review 2.  Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders.

Authors:  E M Sorkin; S P Clissold; R N Brogden
Journal:  Drugs       Date:  1985-09       Impact factor: 9.546

3.  Influence of a variant angina on the results of percutaneous transluminal coronary angioplasty.

Authors:  F Leisch; W Schützenberger; K Kerschner; W Herbinger
Journal:  Br Heart J       Date:  1986-10

4.  Differential effects of sympathetic activity on AV junctional automaticity and AV conduction.

Authors:  F Urthaler; B H Neely; G R Hageman; L R Smith
Journal:  Basic Res Cardiol       Date:  1986 Sep-Oct       Impact factor: 17.165

Review 5.  Adverse reactions to calcium antagonists.

Authors:  J G Lewis
Journal:  Drugs       Date:  1983-02       Impact factor: 9.546

6.  Acute spasm of vein bypass graft and recipient artery in the immediate postoperative period.

Authors:  T E Dye; P Gregor; T F Murphy
Journal:  Tex Heart Inst J       Date:  1984-06

Review 7.  Calcium antagonists. Clinical use in the treatment of angina.

Authors:  P Théroux; Y Taeymans; D D Waters
Journal:  Drugs       Date:  1983-02       Impact factor: 9.546

8.  Influence of intracoronary nifedipine on left ventricular function, coronary vasomotility, and myocardial oxygen consumption.

Authors:  P W Serruys; T E Hooghoudt; J H Reiber; C Slager; R W Brower; P G Hugenholtz
Journal:  Br Heart J       Date:  1983-05

Review 9.  The haemodynamic effects of nifedipine, verapamil and diltiazem in patients with coronary artery disease. A review.

Authors:  A L Soward; G L Vanhaleweyk; P W Serruys
Journal:  Drugs       Date:  1986-07       Impact factor: 9.546

Review 10.  Microvascular angina: angina that predominantly affects women.

Authors:  Jin Joo Park; Sung-Ji Park; Dong-Ju Choi
Journal:  Korean J Intern Med       Date:  2015-02-27       Impact factor: 2.884

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.